While vaccines are one of the most powerful public health tools for protecting against infectious disease, not everybody is conferred the same level of protection. Many factors determine whether an individual responding to vaccination will generate an effective response, including specific b
Many factors determine whether an individual responding to vaccination will generate an effective response, including specific biomarkers within a person's immune system.
Union Minister of Chemicals and Fertilizers Mansukh Mandaviya inaugurated 12th Edition of India Chem-2022 with the theme "Vision 2030: Chemicals and Petrochemicals Build India" at New Delhi.
White House COVID-19 Response Coordinator Dr Ashish Jha called India a major exporter of vaccines in the world because of its incredible manufacturing capacity.
Since January this year, 29 countries have reported cholera cases, including Haiti, Malawi and Syria which are facing large outbreaks. In comparison, in the previous 5 years, fewer than 20 countries on average reported outbreaks. The global trend is moving towards more numerous, more widespr
The new study led by the University of Waterloo aimed to investigate the relationship between vaccine hesitancy, psychological factors associated with anxiety, and individuals' reasoning for and against getting the COVID-19 vaccine.
London [UK], October 24 (ANI): Britain's former Finance Minister Rishi Sunak on Monday praised the leadership of former UK Prime Minister Boris Johnson as the latter pulled out of the Conservative Party leadership race.
New Delhi [India], October 21 (ANI): Chief Scientist at World Health Organisation (WHO) Dr Soumya Swaminathan has said that it's very important for India to have a strong regulatory system to remain a leader in the generic medicine and vaccines space.
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to C